Dr. Jonathan E. Kolitz, MD

Dr. Kolitz practices at Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York.

Dr. Kolitz's NPI, 1770653115, was assigned on November 9, 2006. Dr. Kolitz graduated from Yale School of Medicine in 1979. Dr. Kolitz holds New York license 144370.

Dr. Kolitz's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center, at 450 Lakeville Rd, Lake Success, NY 11042. The practice phone is (516) 734-8281.

Dr. Kolitz's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York. Dr. Kolitz is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Kolitz to 1 more hospital, 2 group practices and clinics, 1 clinical lab, 1 home health agency and 1 medical group, each named with a free account. Dr. Kolitz's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolitz practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kolitz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kolitz is board certified in hematology by the American Board of Internal Medicine. Dr. Kolitz is licensed in New York.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Kolitz treats.

CMS data shows 1,547 Medicare services from Dr. Kolitz across 7 procedure codes in 2024, for 380 Medicare patients. Medicare paid $118,841 for them.

CMS counts 380 Medicare patients who saw Dr. Kolitz in 2024. The largest group is 75 to 84, with 164 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kolitz's median patient age at 74, with 49% women.

In 2024, Dr. Kolitz wrote 115 Medicare Part D claims for 44 patients. 80% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $44 in total drug cost. In 2022, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Kolitz for performance year 2024, reported as part of a group. Dr. Kolitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kolitz as offering telehealth.

Dmand AI links 210 papers to Dr. Kolitz, published from 2003 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Leukemia, Lymphocytic, Chronic, B-Cell. Dr. Kolitz has published most often in Blood. Dr. Kolitz's most frequent co-authors are Richard A. Larson, Bayard Lowery Powell, MD and Steven L. Allen.

Dmand AI links Dr. Kolitz to 15 clinical trials, 6 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Burkitt Lymphoma. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 53 general payments to Dr. Kolitz from 10 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 79% of the total. Daiichi Sankyo Inc. paid the most, $9,248.

Dmand AI lists 7 awards for Dr. Kolitz, most recently Top Doctors: New York Metro Area in 2018.

Dr. Kolitz graduated from Yale School of Medicine in 1979. Dr. Kolitz is a member of Alliance for Clinical Trials in Oncology/CALGB, ACP, ASCO and ASH.

Dr. Kolitz is in network with 5 carriers, including Aetna, Cigna and MVP Health Care. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.